House Concurrent Resolution 22
116th Congress(2019-2020)
Exposing Congressional Drug Abuse Act
Introduced
Introduced in House on Feb 27, 2019
Origin Chamber
House
Type
Concurrent Resolution
Concurrent Resolution
A form of legislative measure used for the regulation of business within both chambers of Congress, not for proposing changes in law. Depending on the chamber of origin, they begin with a designation of either H.Con.Res. or S.Con.Res. Joint resolutions and simple resolutions are other types of resolutions.
Bill Number
22
Congress
116
Policy Area
Congress
Congress
Primary focus of measure is Members of Congress; general congressional oversight; congressional agencies, committees, operations; legislative procedures; U.S. Capitol. Measures concerning oversight and investigation of specific matters may fall under the issue-specific relevant policy area.
No House votes have been held for this bill.
Summary
Exposing Congressional Drug Abuse Act
This concurrent resolution requires each Member of Congress, including a Delegate or Resident Commissioner, to submit to random tests for illegal use of controlled substances.
February 27, 2019
02/27/2019
Referred to the House Committee on House Administration.
02/27/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 4:47:43 PM